...
首页> 外文期刊>Haematologica >Effect of cold-storage in the accumulation of bioreactive substances in platelet concentrates treated with second messenger effects | Haematologica
【24h】

Effect of cold-storage in the accumulation of bioreactive substances in platelet concentrates treated with second messenger effects | Haematologica

机译:第二信使效应处理后的冷藏对浓缩血小板浓缩物中生物反应性物质积累的影响血液学

获取原文
           

摘要

BACKGROUND AND OBJECTIVES. The mandatory 5-day of shelf-life platelet concentrates (PCs) creates outdating and inventory control problems in blood banking. Moreover, storage of PCs at 22-24 degrees C has been associated with a time-dependent accumulation of pyrogenic cytokines, potentially harmful for recipients. Previous studies have shown that supplementation of PCs with ThromboSol, a mixture of second-messengers effectors, might allow storage of functionally active platelets at refrigerated temperature to be extended. This study further investigates this storage approach by comparing the accumulation of bioactive compounds in standard and refrigerated PCs. DESIGN AND METHODS. The PCs were supplemented with ThromboSol or a control solution and stored in parallel at 24 degrees C with continuous agitation or undisturbed at 4 degrees C. Samples were removed on days 1, 5, 9 of storage, and assayed for their content of interleukin (IL)-6, IL-8, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, and anaphylatoxins C3a and C4a. RESULTS. Throughout storage, refrigerated PCs, both ThromboSol-treated and untreated units, displayed a slightly lower level of IL-6 and significantly lower concentration of IL-8 than conventionally stored PCs. ThromboSol slightly reduced the level of these cytokines in PCs. Throughout storage at 22 degrees C, an accumulation of anaphylatoxins C3a and C4a was seen both in both control and ThromboSol-treated PCs. This accumulation was significantly reduced in control PCs stored at 4 degrees C, but not in refrigerated PCs supplemented with ThromboSol. Cold-storage, with or without ThromboSol, had a minor effect on the accumulation of TGF-beta1 in PCs. INTERPRETATION AND CONCLUSIONS. Our data confirm that release of bioactive compounds during in vitro storage of PCs is a temperature-sensitive process. The ThromboSol-refrigeration system could be a useful alternative for extending storage of PCs, without increasing the accumulation of cytokines (IL-6, IL-8), known to be involved in febrile reactions in recipients. Nevertheless, this storage system has no benefit on the level of other bioactive compounds (TGF-beta1, anaphylatoxins C3a and C4a) in PCs.
机译:背景和目标。保质期为5天的浓缩血小板浓缩物(PC)会在血库中造成过时和库存控制问题。此外,PC在22-24摄氏度下的存储与热源性细胞因子的时间依赖性积累有关,这可能会对受体产生危害。先前的研究表明,向PC补充ThromboSol是第二信使效应的混合物,可以延长功能活性血小板在冷藏温度下的储存。这项研究通过比较标准和冷藏PC中生物活性化合物的积累,进一步研究了这种存储方法。设计和方法。在PC上添加ThromboSol或对照溶液,并在24°C下连续搅动平行存储或在4°C下不受干扰。在存储的第1、5、9天取出样品,并分析其白介素(IL)的含量)-6,IL-8,肿瘤坏死因子(TNF)-alpha,转化生长因子(TGF)-beta1和过敏毒素C3a和C4a。结果。在整个存储过程中,与传统存储的PC相比,经过ThromboSol处理和未处理的冷藏PC均显示出较低的IL-6水平和显着较低的IL-8浓度。 ThromboSol稍微降低了PC中这些细胞因子的水平。在22摄氏度下的整个存储过程中,在对照和ThromboSol处理的PC中均发现了过敏毒素C3a和C4a的积累。在4摄氏度下存储的对照PC中,这种积累明显减少了,但是在补充有ThromboSol的冷藏PC中却没有。有或没有ThromboSol的冷存储对PC中TGF-beta1的积累影响不大。解释和结论。我们的数据证实,在PC的体外存储过程中释放生物活性化合物是对温度敏感的过程。 ThromboSol制冷系统可能是扩展PC存储的有用选择,而不会增加已知参与受体发热反应的细胞因子(IL-6,IL-8)的积累。但是,此存储系统对PC中其他生物活性化合物(TGF-beta1,过敏毒素C3a和C4a)的水平没有好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号